Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.10.2022 | Case report

Camrelizumab/lenvatinib

Mycobacterium neoaurum infection (first report), catheter-associated bloodstream infection, psoriasis exacerbation and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
  • * First published case report
Literatur
Zurück zum Zitat Pang L, et al. Case report: Mycobacterium neoaurum infection during ICI therapy in a hepatocellular carcinoma patient with psoriasis. Frontiers in Immunology 13: 22 Aug 2022. Available from: URL: https://www.frontiersin.org/journals/immunology# Pang L, et al. Case report: Mycobacterium neoaurum infection during ICI therapy in a hepatocellular carcinoma patient with psoriasis. Frontiers in Immunology 13: 22 Aug 2022. Available from: URL: https://www.frontiersin.org/journals/immunology#
Metadaten
Titel
Camrelizumab/lenvatinib
Mycobacterium neoaurum infection (first report), catheter-associated bloodstream infection, psoriasis exacerbation and lack of efficacy: case report
Publikationsdatum
01.10.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-25372-7

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Asciminib

Case report

Multiple drugs